A project from the American Society of Retina SpecialistsSign in to view content
Interim Safety and Efficacy Results From the Phase 1 HELIOS Trial of Sustained-Release Axitinib Implant (OTX-TKI) for NPDR
- Video
- Published 2024
Related
Category: Diabetic Retinopathy